Sign in

CIK 0000908259 · Non-accelerated filer<br>Smaller reporting company

Oncotelic Therapeutics, Inc.

Sign in to watch
Ticker
OTLC
Exchange
OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
133679168
Phone
650-635-7000
Business address
29397 AGOURA RD., #107, AGUORA HILLS, CA, 91301
Former names
MATEON THERAPEUTICS INC, OXIGENE INC
  1. 4 Open-market buy CHAIRMAN AND CEO bought 1,356,990 shares at an average $0.02 ($23,537)
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Open-market buy CHAIRMAN AND CEO bought 240,000 shares at $0.04 ($10,344)
  9. 4 Open-market buy CHAIRMAN AND CEO bought 255,000 shares at $0.05 ($11,475)
  10. 4 Open-market buy CFO bought 20,000 shares at $0.05 ($1,000)
  11. 4 Open-market buy CHAIRMAN AND CEO bought 335,759 shares at an average $0.04 ($15,013)
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Open-market buy CHAIRMAN AND CEO bought 198,737 shares at $0.01 ($994)
  15. 4 Open-market buy CHAIRMAN AND CEO bought 346,844 shares at $0.03 ($9,712)
  16. 4 Open-market buy CHAIRMAN AND CEO bought 298,499 shares at $0.03 ($8,627)
  17. 4 Open-market buy CHAIRMAN AND CEO bought 500,000 shares at $0.02 ($10,000)
  18. 4 Open-market buy CHAIRMAN AND CEO bought 500,000 shares at an average $0.02 ($10,875)
  19. 4 Open-market buy CHAIRMAN AND CEO bought 100,000 shares at $0.03 ($2,600)
  20. 4 Open-market buy CHAIRMAN AND CEO bought 400,000 shares at $0.03 ($13,040)

Page 1 of 17 · 325 filings